Next-gen enVVe Position enVVeno Medical as advancing the next-generation enVVe System for deep venous disease, highlighting the upcoming generation as a growth driver and a reason for surgeons and hospitals to engage now for early access, trials, or partnerships.

Clinical validation Leverage recent data presentations and pivotal trial updates (including interim data at SVS and one-year follow-ups at the American Venous Forum) to drive conversations about efficacy, patient outcomes, and payer value with clinicians and hospital procurement teams.

Strategic financing With a solid funding base and a newly appointed CFO, target financial decision-makers at hospitals and health systems to discuss ROI, total cost of ownership, and timelines for adoption tied to the company’s revenue trajectory and potential funding milestones.

Industry partnerships Explore collaborations with vascular centers, academic medical centers, and MedTech distributors attending SVS, Webull Corporate Connect, and other conferences to expand market access, training programs, and case-volume growth for venous disease solutions.

Market readiness Highlight the company’s positioning alongside peers in high-growth aesthetics and medical devices, underscoring readiness for commercialization, payer acceptance, and scalable production to meet increasing demand for advanced venous therapies.